Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases
Giuliana Cassinelli(Fondazione IRCCS Istituto Nazionale dei Tumori), Cinzia Lanzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Franco Zunino(University of California, Berkeley), Marcella De Maglie(University of Milan), Monica Tortoreto(Fondazione IRCCS Istituto Nazionale dei Tumori), Gian Paolo Dagrada(Fondazione IRCCS Istituto Nazionale dei Tumori), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Silvana Pilotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Laura Dal Bo(Fondazione IRCCS Istituto Nazionale dei Tumori), Enrica Favini(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 49
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum
|American Journal Of Pathology|1998|275